Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1.
Mitchell. Dianne C DC; Abdelrahim. Maen M; Weng. Jinsheng J; Stafford. Lewis J LJ; Safe. Stephen S; Bar-Eli. Menashe M; Liu. Mingyao M
Key Findings
- KiSS-1 acts as a metastasis‑suppressor gene but is often silenced in aggressive breast cancers
- AP-2α and Sp1 proteins together boost KiSS-1 gene activity, even though AP-2α doesn’t bind directly to the KiSS-1 promoter
- Loss of AP-2α may explain reduced KiSS-1 levels and higher metastatic potential
Practical Outcomes
- For biohackers, this research doesn’t provide a direct way to use kisspeptin‑10 for health or performance. It highlights a complex gene‑regulation mechanism that would require targeted molecular interventions, which are not currently safe or practical for self‑experimentation.
Summary
The study shows that a gene called KiSS-1, which can help stop cancer spread, is turned off in aggressive breast cancer cells because two proteins, AP-2α and Sp1, aren’t working together properly. It’s a basic science finding about how cancer cells silence a protective gene, not a guide for using kisspeptin as a supplement or therapy.
Abstract
KiSS-1 has been shown to function as a tumor metastasis suppressor gene and reduce the number of metastases in different cancers. The expression of KiSS-1 or KiSS1, like other tumor suppressor, is commonly reduced or completely ablated in a variety of cancers via an unknown mechanism. Here we show that the loss of KiSS-1 expression in highly metastatic breast cancer cell lines correlates directly with the expression levels of two transcription factors, activator protein-2alpha (AP-2alpha) and specificity protein 1 (Sp1), which synergistically activate the transcriptional regulation of KiSS-1 in breast cancer cells. Although the KiSS-1 promoter contains multiple AP-2alpha binding elements, AP-2alpha-mediated regulation occurs indirectly through Sp1 sites, as determined by deletion and mutation analysis. Overexpression of AP-2alpha into highly metastatic breast cell lines did not alter KiSS-1 promoter-driven luciferase gene activity. However, co-transfection of AP-2alpha wild-type or the dominant negative form of AP-2 lacking its C-terminal DNA-binding domain, AP-2B, together with Sp1, increased KiSS-1 promoter activity dramatically, suggesting that AP-2alpha regulation of KiSS-1 transcription does not require direct binding to the KiSS-1 promoter. Furthermore, we demonstrated that AP-2alpha directly interacted with Sp1 to form transcription complexes at two tandem Sp1-binding sites of the promoter to activate KiSS-1 transcription. Together, our results indicate that AP-2alpha and Sp1 are strong transcriptional regulators of KiSS-1 and that loss or decreased expression of AP-2alpha in breast cancer may account for the loss of tumor metastasis suppressor KiSS-1 expression and thus increased cancer metastasis.
Study Information
pubmed
2005
2005-10-27T00:00:00.000Z
10.1074/jbc.m506245200